Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 209

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Low-Dose Hydrochlorothiazide and Preservation of Bone Mineral Density in Older Adults: A Randomized, Double-Blind, Placebo-Controlled Trial

LaCroix, Andrea Z., Ott, Susan M., Ichikawa, Laura, Scholes, Delia, Barlow, William E. · 2000 · Annals of Internal Medicine

Abstract

BACKGROUND: Thiazide may have beneficial effects on bone mineral density and may reduce risk for hip fracture. However, the existence of a causal role remains uncertain because experimental evidence is limited. OBJECTIVE: To determine the effect of hydrochlorothiazide on rates of bone loss in older adults. DESIGN: Randomized, double-blind, placebo-controlled trial with 3-year follow-up. SETTING: A large health maintenance organization in western Washington State. PARTICIPANTS: 320 healthy, normotensive adults (205 women, 115 men) 60 to 79 years of age. INTERVENTION: Random assignment to one of three study groups: 12.5 mg of hydrochlorothiazide per day, 25 mg of hydrochlorothiazide per day, or placebo. MEASUREMENTS: Bone mineral density using dual-energy x-ray absorptiometry at the total hip, posterior-anterior spine, and total body; blood and urine markers of bone metabolism; incident falls, clinical fractures, and radiographic vertebral fractures. RESULTS: 309 of 320 participants completed the 36-month visit (97%). Adherence to study medication throughout follow-up was high in all participants (81.6% to 89.7%) except men in the high-dose hydrochlorothiazide group (60.5%). According to intention-to-treat analysis, the 36-month differences in percentage change in total hip bone mineral density were 0.79 percentage point (95% CI, -0.12 to 1.71) for the 12.5-mg hydrochlorothiazide group and 0.92 percentage point (CI, -0.001 to 1.85) for the 25-mg group compared with placebo (P = 0.03). Percentage change at the posterior-anterior spine was significantly greater for the 25-mg hydrochlorothiazide group at 6 months (intergroup difference, 1.04 percentage points [CI, 0.22 to 1.86]) compared with placebo (P = 0.005); at 36 months, this difference was 0.82 percentage point (CI, -0.36 to 2.01; P = 0.12). No significant differences were seen in total-body bone mineral density between the treatment groups. Treatment effects were stronger in women than in men. CONCLUSIONS: In healthy older adults, low-dose hydrochlorothiazide preserves bone mineral density at the hip and spine. The modest effects observed over 3 years, if accumulated over 10 to 20 years, may explain the one-third reduction in risk for hip fracture associated with thiazide in many epidemiologic studies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.7326/0003-4819-133-7-200010030-00010

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 38

  1. 10.1002/jbmr.5650070902 · DOI · Paper page
  2. 10.1002/jbmr.5650101122 · DOI · Paper page
  3. 10.7326/0003-4819-112-1-29 · DOI · Paper page
  4. 10.1056/NEJM199002013220502 · DOI · Paper page
  5. 10.7326/0003-4819-118-9-199305010-00002 · doi:10.7326/0003-4819-118-9-199305010-00002
  6. 10.1093/oxfordjournals.aje.a008920 · DOI · Paper page
  7. 10.1007/BF01623465 · DOI
  8. 10.1136/bmj.292.6524.861 · DOI
  9. 10.1016/S0140-6736(89)92205-8 · DOI · Paper page
  10. 10.1001/jama.1991.03460030076032 · DOI
  11. 10.1016/0895-4356(95)00552-8 · DOI
  12. 10.1093/oxfordjournals.aje.a009171 · DOI · Paper page
  13. 10.1056/NEJM198308113090605 · DOI · Paper page
  14. 10.1136/bmj.301.6764.1303 · DOI
  15. 10.1093/oxfordjournals.aje.a116954 · DOI
  16. 10.7326/0003-4819-118-9-199305010-00001 · DOI · Paper page
  17. 10.1002/jbmr.5650101121 · DOI · Paper page
  18. 10.1016/S0169-6009(08)80119-5 · doi:10.1016/s0169-6009(08)80119-5
  19. 10.1016/0026-0495(82)90115-9 · doi:10.1016/0026-0495(82)90115-9
  20. 10.1007/BF01774014 · doi:10.1007/bf01774014
  21. 10.1093/oxfordjournals.aje.a009203 · DOI · Paper page
  22. 10.1007/BF01623005 · DOI · Paper page
  23. 10.1001/jama.1989.03430070055030 · DOI · Paper page
  24. 10.1093/oxfordjournals.aje.a116747 · DOI · Paper page
  25. 10.1056/NEJM199709043371003 · DOI · Paper page
  26. LaCroix AZ, 1991, Compr Ther, 17, 30
  27. 10.1111/j.1532-5415.1988.tb04367.x · DOI
  28. 10.5694/j.1326-5377.1993.tb121839.x · DOI
  29. 10.7326/0003-4819-115-1-1 · DOI
  30. 10.2165/00002512-199812010-00005 · DOI · Paper page
  31. Jones G, 1995, J Bone Miner Res, 10, 106, 10.1002/jbmr.5650100115 · DOI
  32. Heshmati HM, 1998, J Clin Endocrinol Metab, 83, 1916
  33. 10.1111/j.1699-0463.1989.tb00792.x · DOI
  34. 10.1038/ki.1996.461 · doi:10.1038/ki.1996.461
  35. 10.1152/ajpcell.1997.272.1.C109 · doi:10.1152/ajpcell.1997.272.1.c109
  36. 10.1001/jama.1997.03540330061036 · DOI · Paper page
  37. 10.1001/archinte.1995.00430080067009 · doi:10.1001/archinte.1995.00430080067009 · Paper page
  38. 10.1001/jama.1997.03550210043036 · DOI

Cited by

See all 209

Metadata

Authors
LaCroix, A. Z., Ott, S. M., Ichikawa, L., Scholes, D., & Barlow, W. E.
Venue
Annals of Internal Medicine
Published
2000-10-03
Volume
133
Issue
7
Pages
516-526
ISSN
  • 0003-4819 (ISSN-L)
  • 1539-3704
OpenAlex
W1980061532
Cited by
209
References
1
FWCI
10.94
Type
journal article
Language
en
Open access
closed
Licence
www.acpjournals.org/journal/aim/text-and-data-mining (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Low-Dose Hydrochlorothiazide and Preservation of Bone Mineral Density in Older Adults: A Randomized, Double-Blind, Placebo-Controlled Trial. https://app.cochat.ai/papers/10.7326/0003-4819-133-7-200010030-00010
The paper
LaCroix, A. Z., Ott, S. M., Ichikawa, L., Scholes, D., & Barlow, W. E. (2000). Low-Dose Hydrochlorothiazide and Preservation of Bone Mineral Density in Older Adults: A Randomized, Double-Blind, Placebo-Controlled Trial. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-133-7-200010030-00010

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.